Establishment Labs Holdings Inc. (ESTA)
NASDAQ
Real-time Data
01:30 PM
Day's Range
71.0152 wk Range
36.53Overview - ESTA - Establishment Labs Holdings Inc.
Key Statistics
Valuation
Enterprise Value
2.32B
P/E (Trailing)
‪-42.23‬
P/E (Forward)
‪1,215.75‬
PEG Ratio
‪1.33‬
Price / Sales (TTM)
‪8.84‬
Price / Book
‪100.61‬
EV / EBITDA
‪-258.67‬
Profitability
Gross Margin
‪70.63%‬
Profit Margin
‪-15.82%‬
Operating Margin
‪-6.35%‬
Return on Assets
‪-3.44%‬
Return on Equity
‪-175.30%‬
Ownership
Shares Outstanding
29.79M
Float
19.55M
Short % of Shares Outstanding
‪18.23%‬
Held by Insiders
‪10.02%‬
Held by Institutions
‪106.12%‬
Price stats
Beta
‪1.08‬
50-Day Avg
‪86.19‬
200-Day Avg
‪72.76‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
9 analysts
Average price target
‪$ 102.44‬Shariah Compliance
Report Date: Feb 18, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ESTA - Establishment Labs Holdings Inc.
Peers - ESTA - Establishment Labs Holdings Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
Profile Summary - ESTA - Establishment Labs Holdings Inc.
About
Establishment Labs Holdings Inc. is a medical technology company that manufactures and markets medical devices for aesthetic and reconstructive plastic surgeries. Its primary products include silicone gel-filled breast implants and body-shaping implants under the renowned Motiva Implants brand, featuring advanced…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
